Squarepoint
HCAT icon

Squarepoint’s Health Catalyst HCAT Stock Holding History

Squarepoint’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.7K Sell
30,438
-158,240
-84% -$298K ﹤0.01% 4155
2025
Q4 		$451K Buy
188,678
+172,379
+1,058% +$471K ﹤0.01% 3292
2025
Q3 		$46.5K Sell
16,299
-28,028
-63% -$95.9K ﹤0.01% 4235
2025
Q2 		$167K Buy
44,327
+7,784
+21% +$30.6K ﹤0.01% 4032
2025
Q1 		$166K Buy
+36,543
New +$193K ﹤0.01% 4084
2024
Q4 		– Sell
-23,708
Closed -$193K – 5201
2024
Q3 		$193K Sell
23,708
-71,755
-75% -$519K ﹤0.01% 3696
2024
Q2 		$610K Sell
95,463
-96,341
-50% -$618K ﹤0.01% 2926
2024
Q1 		$1.44M Buy
191,804
+154,069
+408% +$1.41M ﹤0.01% 2323
2023
Q4 		$349K Buy
+37,735
New +$308K ﹤0.01% 3256
2023
Q3 		– Sell
-10,016
Closed -$125K – 3975
2023
Q2 		$125K Buy
+10,016
New +$119K ﹤0.01% 3319
2023
Q1 		– Sell
-176,530
Closed -$1.88M – 3436
2022
Q4 		$1.88M Buy
176,530
+159,485
+936% +$1.54M 0.01% 1404
2022
Q3 		$165K Sell
17,045
-199,917
-92% -$2.65M ﹤0.01% 2726
2022
Q2 		$3.14M Buy
216,962
+162,297
+297% +$2.77M 0.02% 924
2022
Q1 		$1.43M Buy
54,665
+35,680
+188% +$1.01M 0.01% 1372
2021
Q4 		$752K Buy
18,985
+4,389
+30% +$200K ﹤0.01% 1878
2021
Q3 		$730K Buy
14,596
+2,870
+24% +$157K ﹤0.01% 1750
2021
Q2 		$651K Sell
11,726
-30,155
-72% -$1.61M ﹤0.01% 1951
2021
Q1 		$1.96M Buy
41,881
+3,830
+10% +$186K 0.01% 1082
2020
Q4 		$1.66M Sell
38,051
-8,610
-18% -$318K 0.01% 1036
2020
Q3 		$1.71M Buy
46,661
+7,111
+18% +$241K 0.02% 710
2020
Q2 		$1.15M Buy
+39,550
New +$1.09M 0.02% 858

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's HCAT Position: Q1 2026 in Review

Squarepoint reduced its Health Catalyst (HCAT) stake by 84% in Q1 2026, selling an estimated $298K and leaving 30,438 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4155.

Squarepoint first reported a position in HCAT in Q2 2020 and has held it in 21 quarters since. The position peaked at $3.14M in Q2 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Squarepoint held 30,438 shares of Health Catalyst worth $38.7K as of Q1 2026.
  • Squarepoint sold 158,240 Health Catalyst shares in Q1 2026, an estimated $298K.
  • Health Catalyst made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4155 holding.
  • Squarepoint first reported a position in Health Catalyst in Q2 2020 and has held it in 21 quarters since.
  • Squarepoint's Health Catalyst position peaked at $3.14M in Q2 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.